FundedIQ
Biotechnology

AllRock Bio: Funding, Investors & Team (Sep 2026)

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

allrockbio.com LinkedIn Boston, United States 11-50 employees
Total raised
$50.0M
Rounds
1
Latest
Series A
Sep 2025

AllRock Bio has raised $50.0M across 1 funding round on record, the most recent a Series A of $50.0M announced in Sep 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AllRock Bio Company Profile and Key Stats

Total funding raised
$50.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$50.0M in Sep 2025
Employees
11-50
reported band
Headquarters
Boston, United States

Latest funding round on record: Sep 2025.

AllRock Bio Funding Rounds

Date
Round
Amount
Series A
$50.0M

AllRock Bio Founders and Leadership Team

Name
Role
Contact
Catherine Pearce
Locked

Contact details for the AllRock Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

AllRock Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
8,378
$15M

AllRock Bio's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AllRock Bio in Biotechnology and Boston

Companies Similar to AllRock Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

AllRock Bio Funding FAQs

What does AllRock Bio do?

AllRock Bio is a drug developing firm that offers novel therapies to patients suffering hypertension and other fibrotic conditions.

How much funding has AllRock Bio raised?

AllRock Bio has raised $50.0M across 1 round on record. The most recent is a Series A of $50.0M announced in Sep 2025.

When did AllRock Bio last raise funding?

AllRock Bio's most recent funding round on record is a Series A of $50.0M, announced in Sep 2025.

Where is AllRock Bio headquartered?

AllRock Bio is based in Boston, United States.

How many employees does AllRock Bio have?

AllRock Bio is in the 11-50 employee band.

How does AllRock Bio's funding compare to other Biotechnology startups?

AllRock Bio's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's AllRock Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AllRock Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.